# Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study

> **NCT05498584** · — · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 130 (estimated)

## Conditions studied

- Heart Failure; With Decompensation

## Interventions

- **BEHAVIORAL:** exercise based cardiac rehabilitation

## Key facts

- **NCT ID:** NCT05498584
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-25
- **Primary completion:** 2025-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498584, "Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05498584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*